Already a member? Login to access this report free.
Report Highlights
The global market for oligonucleotides is expected to grow from $7.0 billion in 2023 and projected to reach $11.7 billion by the end of 2028, at a compound annual growth rate (CAGR) of 11.0% during the forecast period of 2023 to 2028.
Report Includes
- 31 data tables and 48 additional tables
- Overview and an analysis of the global markets for oligonucleotides
- Analyses of the global market trends, with historical market revenue data (sales figures) from 2020 to 2022, estimates for 2023, and projections of compound annual growth rates (CAGRs) through 2028
- A discussion of the current and future market potential of oligonucleotide synthesis, as well as the competitive landscape, market dynamics, ongoing research, and trends in market growth
- Estimate of the market size and revenue forecasts, and a corresponding market share analysis based on product type, application and region
- Coverage of the total market for oligonucleotide synthesis, which includes RNA oligos, DNA oligos, and the platform services offered by many companies
- Overview of the sustainability trends and ESG developments, with an emphasis on consumer attitudes, ESG score analysis, and the ESG practices followed by leading companies
- A look at the recent developments in the market and emerging technologies
- An analysis of the key patents and recent clinical trials on oligonucleotide synthesis-based products and applications
- Competitive intelligence, including the major vendors’ market shares, recent M&A activity, and venture funding outlook
- Profiles of the leading global players, including Thermo Fisher Scientific Inc., Agilent Technologies, Inc., Integrated DNA Technologies, Inc., Eurofins Scientific, and Biolytic Lab Performance Inc.
Report Scope
This report covers the worldwide market for oligonucleotide synthesis, which consists of four main product types: oligonucleotide drugs, synthesized oligos, equipment and reagents, and services. Based on application, the market for oligonucleotide synthesis is divided into research and diagnostics and therapeutics.
By geography, the market in this report is divided into four regions: North America, Europe, Asia-Pacific, and Rest of the World (RoW). For market estimates, data has been provided for 2022 as the base year, with forecasts for 2023 through 2028.
The report also covers approved drugs, the oligonucleotide synthesis process, innovative research, opportunities within the market and profiles of leading companies in the oligonucleotide synthesis industry.
Report Synopsis
| Report Metrics | Details | ||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Base year considered | 2022 | ||||||||||||
| Forecast period considered | 2023-2028 | ||||||||||||
| Base year market size | $6.3 billion | ||||||||||||
| Market size forecast | $11.7 billion | ||||||||||||
| Growth rate | CAGR of 11.0% for the forecast period of 2023-2028 | ||||||||||||
| Units considered | $ Millions | ||||||||||||
| Segments covered | Type, Application, and Region | ||||||||||||
| Regions covered | North America, Europe, Asia-Pacific, and Rest of the World | ||||||||||||
| Countries covered | U.S., Canada, Germany, U.K., France, Italy, Spain, China, Japan, India | ||||||||||||
| Key Market Drivers |
|
||||||||||||
| Companies studied |
|
||||||||||||
Frequently Asked Questions (FAQs)
Analyst Credentials
BCC Research Team possesses expertise and experience in life and physical science domains. They specialize in offering valuable business insights, including industry analysis, competitor intelligence, strategic and financial analysis, and opportunity assessment. The team has in-depth knowledge of various sectors, including healthcare, biotechnology, pharmaceuticals, IT, automation, advanced materials, and energy. They are proficient in qualitative and quantitative market intelligence providing clients with actionable insights. With a vast understanding of the competitive landscape, the team can support clients in making data-driven decisions to help them achieve a competitive edge in their respective markets.
Report Highlights
The global market for oligonucleotide synthesis should grow from $6.1 billion in 2021 to $10.2 billion by 2026 with a compound annual growth rate (CAGR) of 10.7% for the period of 2021-2026.
Report Includes
- 22 data tables and 20 additional tables
- An overview of the global market for oligonucleotides
- Estimation of the market size and analyses of global market trends, with data from 2019, 2020, estimates for 2021 and projections of compound annual growth rates (CAGRs) through 2026
- Evaluation of current market trends, and technological advancements within the industry and market share analysis of oligonucleotides by type, application, and region
- Information on the classifications and applications of oligonucleotides and detailed description of DNA oligos and RNA oligos synthesis
- Details of solid phase chemical synthesis and alternative forms of oligonucleotide synthesis processes and insights into government regulations for oligonucleotide-based drugs
- Information on CRISPR-Cas diagnosis and therapeutic tools for SARS-CoV-2 infection, and discussion on ASO as a COVID-19 therapeutic
- A look at the new product developments, clinical trials, patents, mergers and acquisitions and collaborations or partnership of the industry
- Company profiles of major players of the industry, including Agilent Technologies , Eurofins Scientific, Biolegio, Merck KGaA , Integrated DNA Technologies and Thermo Fisher Scientific
Related Reports
2024 DNA and RNA Synthesis Research Review
The Cell Biology industry is a multi-billion-dollar industry whose outlook is supposed to rise in the coming years. This report provides a sampling of the types of quantitative market information, analysis and guidance that has been aiding business decision making since the inception of BCC Research in 1971.
Global DNA Sequencing: Research, Applied and Clinical Markets
The global market for DNA sequencing is expected to grow from $14.8 billion in 2024 and is projected to reach $34.8 billion by the end of 2029, at a compound annual growth rate (CAGR) of 18.6% during the forecast period of 2024 to 2029.
Cell and Gene Therapy Tools, and Reagents: Global Markets
The global market for Cell and Gene Therapy (CGT) Tools and Reagents is estimated to increase from $10.0 billion in 2024 to reach $16.7 billion by 2029, at a compound annual growth rate (CAGR) of 10.8% from 2024 through 2029.
RNAi Technologies and Global Markets
The global market for RNAi technology is estimated to increase from $2.1 billion in 2023 to reach $4.8 billion by 2029, at a compound annual growth rate (CAGR) of 14.8% from 2024 through 2029.
Recent Reports
Proteomics: Technologies and Global Markets
The global market for proteomic technologies was valued at $27.6 billion in 2024. It is projected to grow from $31.0 billion in 2025 to $57.2 billion by the end of 2030, at a compound annual growth rate (CAGR) of 13.0% from 2025 to 2030.
Biologic Therapeutic Drugs: Technologies and Global Markets
The global market for biologic therapeutic drugs is estimated to increase from $499.2 billion in 2024 to reach $794.5 billion by 2029, at a compound annual growth rate (CAGR) of 9.7% from 2024 through 2029.
Global Markets and Manufacturing Technologies for Protein Drugs
The global protein drugs market is expected to grow from $441.7 billion in 2024 and is projected to reach $655.7 billion by the end of 2029, at a compound annual growth rate (CAGR) of 8.2% during the forecast period of 2024 to 2029.
G-Protein Coupled Receptor (GPCR) Targeting: Technologies and Global Markets
The global G protein-coupled receptor (GPCR) market is expected to grow from $4.4 billion in 2024 and is projected to reach $6.1 billion by the end of 2029, at a compound annual growth rate (CAGR) of 6.8% during the forecast period of 2024 to 2029.
2024 Cell and Gene: Research Review
Research Reviews from BCC Research provide market professionals with concise market coverage within a specific research category. These Research Reviews include portions of several market research reports that were published in 2024.
Top Trending Reports
Global Markets for Emerging Medical Device Technologies
The global market for emerging medical devices is estimated to increase from $136.6 billion in 2024 to reach $223.9 billion by 2029, at a compound annual growth rate (CAGR) of 10.4% from 2024 through 2029.
Global Diabetic Care Devices Market
The global market for diabetes monitoring devices is expected to grow from $16.6 billion in 2024 to $26.8 billion by the end of 2029, at a compound annual growth rate (CAGR) of 10.1% from 2024 through 2029.
Single-Cell Genomics and Proteomics: Emerging Technologies and Markets
The global market for single-cell genomics and proteomics is expected to grow from $4.0 billion in 2024 to reach $9.1 billion by the end of 2029, at a compound annual growth rate (CAGR) of 17.6% from 2024 through 2029.
Global Lithium-ion Battery Market
The global market for lithium-ion battery (LIB) is expected to grow from $117.8 billion in 2024 and is projected to reach $221.7 billion by the end of 2029, at a compound annual growth rate (CAGR) of 13.5% during the forecast period of 2024 to 2029.
2024 Medical Devices Research Review
The medical device industry is a multi-billion-dollar industry whose outlook is supposed to rise in the coming years These devices treat and diagnose a multitude of patient conditions and work much better than drugs.
Become A Member
BCC Research offers a comprehensive library of reports, granting members unlimited access to data, insights, and market intelligence for informed business decisions, while actively supporting members in their evolving journeys and prioritizing high-quality, relevant topics based on continuous engagement with the research community.
Find Out MoreCustom Consulting
BCC Research emphasizes the importance of organizations leveraging highly customized market insights aligned with specific strategic business objectives through direct engagement with primary sources and proprietary forecasting models for profitable decision-making in maximizing growth opportunities and minimizing risks.
Customize NowScorecard
The Venture Scorecard provides commercialization offices and decision makers with expert analysis, offering strategic insights crucial for aligning objectives with market realities at various stages of commercializing new products or evaluating investment opportunities, from opportunity assessment to growth planning.
Find Out MoreInnovation Spotlight
Our industry experts offer strategic guidance to maximize the market potential of commercialized products, patents, and IP by providing insights into market trends, competitive dynamics, and effective positioning, using the Innovation Spotlight service for enhanced exposure to thought leaders and the wider community.
Find Out More